ClinicalTrials.gov
public full text
Public Domain
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
This purpose of this study is to assess the effect of febuxostat, once daily (QD), on joint damage in patients with elevated serum urate levels and gout.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.#890224
- [Association of metabolic syndrome and its components with gout: an analysis based on a large-scale health survey database].#165895
- Lesinurad and Febuxostat Combination Extension Study in Gout#866928
- Global and regional burden of gout in middle-aged adults, 1990-2021, with projections to 2046: An observational study analysis for GBD 2021.#174653
- Comparison of the Effect of Allopurinol Versus Febuxostat on Serum Uric Acid in Patients With Chronic Kidney Disease Associated With Hyperuricemia#1171339
Record · ID 1029838
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive